Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Inherited Metabolic Diseases, |
RCV001358673 | SCV001554466 | likely pathogenic | Spinocerebellar ataxia type 29 | 2021-04-07 | criteria provided, single submitter | clinical testing | |
3billion, |
RCV001358673 | SCV002012085 | likely pathogenic | Spinocerebellar ataxia type 29 | 2021-10-02 | criteria provided, single submitter | clinical testing | The variant was observed as assumed (i.e. paternity and maternity not confirmed) de novoo (3billion dataset, PM6). It is not observed in the gnomAD v2.1.1 dataset (PM2). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.937, 3Cnet: 0.940, PP3). Patient's phenotype is considered compatible with Spinocerebellar ataxia 29, congenital nonprogressive (3billion dataset, PP4). Therefore, this variant is classified as likley pathogenic according to the recommendation of ACMG/AMP guideline. |